-
Full Article (HTML) (32) -
Full Article (PDF) (7)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3034)
All Articles published online
|
Publishing Process of This Article
|
Sep 8, 2015 (publication date) through Sep 23, 2020
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Number | Cited Articles |
| 1 |
Davide Simeone, Anna Maria Spera, G. Tosone, R. Orlando. May direct-acting antiviral regimens for chronic hepatitis C virus infections have neuropsychiatric adverse drug reactions? A pilot study conducted in patients receiving sofosbuvir-based regimens in the real-life setting. Drugs & Therapy Perspectives 2017; 33(9): 442 doi: 10.1007/s40267-017-0422-x
|
| 2 |
Ruben C. Hoogeveen, Max P.A.M. Sonnen, Sanjay U.C. Sankatsing. Visual Hallucinations During Hepatitis C Treatment With Sofosbuvir and Simeprevir. Infectious Diseases in Clinical Practice 2016; 24(6): e65 doi: 10.1097/IPC.0000000000000425
|
| 3 |
Michele Fabrazzo, Rosa Zampino, Martina Vitrone, Gaia Sampogna, Lucia Del Gaudio, Daniela Nunziata, Salvatore Agnese, Anna Santagata, Emanuele Durante-Mangoni, Andrea Fiorillo. Effects of Direct-Acting Antiviral Agents on the Mental Health of Patients with Chronic Hepatitis C: A Prospective Observational Study. Brain Sciences 2020; 10(8): 483 doi: 10.3390/brainsci10080483
|
| 4 |
Marta Miarons, Azhara Sánchez-Ulayar, Glòria Sempere, Sergio Marín, Josep Maria Castellví. New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups. European Journal of Hospital Pharmacy 2019; 26(3): 135 doi: 10.1136/ejhpharm-2017-001352
|
| 5 |
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
|
| 6 |
Bryan Sackey, Jana G. Shults, Troy A. Moore, Rachel Rogers, Mina Mehvar, Joshua G. King. Evaluating psychiatric outcomes associated with direct-acting antiviral treatment in veterans with hepatitis C infection. Mental Health Clinician 2018; 8(3): 116 doi: 10.9740/mhc.2018.05.116
|